Catalent Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 10:15PM GMT
Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst

All right. Let's get started. Good afternoon, everyone. Welcome to day 1 afternoon of the JPMorgan Healthcare Conference. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Catalent. And now with that, let me turn it over to them.

Alessandro Maselli - Catalent, Inc. - CEO & Director

Thank you, Julia. Afternoon, everyone. Welcome, and very glad to be here to present the Catalent story. Before we get started, before we begin, I would like to call your attention to Page 2 and 3 of our presentation with regards to our use of forward-looking statements and non-GAAP financial measures as well as I would like to invite you to read our SEC filings with regard of risks and uncertainty that can bear our future operating results and our financial conditions. With that said, let me start from our mission, right?

At Catalent, we have a very, very clear mission, which is to help people

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot